Location History:
- Basingstoke, GB (2013)
- Hampshire, GB (2018)
Company Filing History:
Years Active: 2013-2018
Title: Innovations of Richard A. Bovill in Selective Cell Inhibition
Introduction
Richard A. Bovill, an accomplished inventor based in Basingstoke, GB, has made significant contributions in the field of biotechnology. With a total of two patents to his name, his work focuses on innovative solutions for selective inhibition of non-target cells in diverse biological applications.
Latest Patents
Bovill's latest patents include "Triclosan Derivatives and Uses Thereof," which presents a selective agent comprising a triclosan derivative aimed at inhibiting non-target cells while allowing target cells to thrive. This invention emphasizes the use of glycoside derivatives, primarily pyranoside derivatives. The selective agent facilitates the cultivation of cells by establishing a medium that ensures only desired cells grow, characterized by a toxic moiety released within non-target cells.
Another notable patent by Bovill, "Selective Growth Media," further advances the field by detailing a method for selectively inhibiting growth in mixed cell populations. This method involves contacting the population with a selective agent that comprises a carrier moiety linked to a toxic moiety via a cleavable linkage, which targets only non-desired cells while leaving target cells unharmed.
Career Highlights
Richard A. Bovill is currently associated with Oxoid Limited, where he utilizes his expertise to develop innovative solutions in microbiology. His contributions have gained recognition for advancing cell culture methodologies and enhancing research capabilities in the field.
Collaborations
Throughout his career, Bovill has collaborated with talented colleagues such as Gemma Howse and Patrick Druggan. Their teamwork embodies a shared vision for innovation, driving significant advancements in their respective fields through collaboration and knowledge exchange.
Conclusion
Richard A. Bovill stands out in the realm of biotechnology and innovation. His pioneering patents focused on selective inhibition of non-target cells present exciting possibilities for future research and applications in cellular biology. The impact of his work continues to shape methodologies for cell culture and microbiological research.